Anti-CD4 (Zanolimumab)-MC-Vc-PAB-MMAE ADC
This ADC product is comprised of an anti-CD4 monoclonal antibody conjugated via a MC-Vc linker to MMAE. The MMAE is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAE binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Product Specifications
CAS Number
9007-83-4
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
123778-HRP 100 µL
B3GNT3 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, BGnT-3, Beta-1,3-Gn-T3, Beta-1,3-N-acetylglucosaminyltransferase 3, Beta3Gn-T3, Beta-1,3-galactosyltransferase 8, Beta-1,3-GalTase 8, Beta3Gal-T8, Beta3GalT8, b3Gal-T8, Beta-3-Gx-T8, Core 1 Extending beta-1,3-N-acetylglucosaminyltransferase, Core1-beta3GlcNAcT, Transmembrane Protein 3, UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 8, UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 8, B3GALT8, TMEM3, UNQ637/PRO1266) (HRP)
Sign In for Pricing
View Details 